Signature Litigation’s Paris office co-founding partner on the French litigation system
Continue reading “Q&A: Sylvie Gallage-Alwis, Signature Litigation”
Q&A: Sylvie Gallage-Alwis, Signature Litigation
Euro Elite 2024: France – More of the same?
Described by Darrois Villey tax partner Loïc Védie as ‘better than expected’, 2023 was nonetheless a year marked by uncertainty for Euro Elite firms in France. Lawyers weathered an often-slow market; interest rates reached significantly higher levels than previous years, which limited the overall number of transactions.
In the corporate and finance arena, equity capital markets experienced a noticeable slowdown, characterised by a subdued market. Debt capital markets, however, showcased vibrancy, with a renewed interest in securitisation and factoring. Influenced by leading US firms, this move shaped the financial landscape for French elites, fostering a more diversified and adaptable approach to funding strategies. The trend underscored a departure from traditional methods, offering heightened flexibility and a broader array of financial instruments, prompting a re-evaluation of established approaches in the dynamic French market. Continue reading “Euro Elite 2024: France – More of the same?”
Sponsored Q&A: Lacourte Raquin Tatar
1. What are the key regulatory frameworks that govern the banking and finance sector in France?
The key regulatory frameworks that govern the banking and finance sector in France are: Continue reading “Sponsored Q&A: Lacourte Raquin Tatar”
Sponsored briefing: France: new regulations on shortages of health products and new challenges for the life sciences sector
Diane Bandon-Tourret, partner and head of the life sciences practice at LexCase, and Tamara Milano, associate in the life sciences practice, consider new regulations in France aimed towards avoiding shortages of medical products
These last years, shortages became a major public health concern, highlighted by the Covid-19 crisis and the current shortages of major medicines. As a result, adoption of new regulations to prevent shortages have become a priority for many countries. In the EU, new regulations have strengthened shortages prevention, such as Regulation (EU) 2023/607 which extended the validity period of CE certificates issued under the previous regulation to avoid the unavailability of medical devices (MDs). In France, regulations on shortages recently evolved in the field of medicines, MDs and in vitro diagnostic devices (IVDs). Continue reading “Sponsored briefing: France: new regulations on shortages of health products and new challenges for the life sciences sector”
Euro Elite 2023: France – Pretty good year
Activity levels bounced back in France in 2021 after the initial impact of the pandemic and this recovery continued apace in 2022.
‘2022 was the best year,’ says Henri Savoie, who heads the public law and regulatory practice at Darrois Villey Maillot Brochier. ‘2023 will be more normal,’ he warns, pointing out that ‘companies will be active, but they will be cautious. It is a trend.’ Continue reading “Euro Elite 2023: France – Pretty good year”
Euro Elite France: Vive l’autonomie
The second year of the Covid-19 crisis has seen French firms busier than ever. Following an initial slowdown between March and May at the beginning of the pandemic, the Paris market has more than picked itself up since early summer 2020. As corporates and investors adapted to life under Covid rules and French courts opened up again, firms across all areas of the legal market report extremely high levels of activity.
As interest rates remain low, firms are struggling to keep pace with the big appetite for mergers and acquisitions. LBO specialists in particular shouldered more transactions in 2021 than in the year before the pandemic hit. The Paris fund formation teams also report a buzzing market, partly caused by a necessity to fund restructurings, but mainly driven by the economy’s staggering comeback. In the venture and growth capital scene, the extremely busy market, and in particular the heavy investments made by US and UK investors, has caused a rise in the number of new firms specialising in venture and growth capital transactions. Continue reading “Euro Elite France: Vive l’autonomie”
Sponsored briefing: New consolidated regime of early access in France
On 14 December 2020, the French Social Security Financing Act for 20211 (article 78) reformed early market access mechanisms in France and simplified the former systems of derogatory reimbursement for medicines, which included the temporary authorisation for use (ATU) and temporary recommendation for use (RTU) regimes.
Two new regimes have been created: early access authorisation (AAP – exceptional use of certain drugs for specific therapeutic indications, intended to treat serious, rare, or disabling diseases) and compassionate use (exceptional use of certain medicines in specific therapeutic indications). Continue reading “Sponsored briefing: New consolidated regime of early access in France”
‘Our first big move’: Bryan Cave Leighton Paisner gets Paris play over the line
Real estate leader taps Franklin for eight partners with more to come in France
‘It’s great to get to the moment where our first big move has happened.’
Lisa Mayhew, Bryan Cave Leighton Paisner
Since the 2018 tie-up between Berwin Leighton Paisner (BLP) and Bryan Cave, the merged entity of Bryan Cave Leighton Paisner (BCLP) has experienced a period of relative calm. But while the last 18 months have been defined by neither convulsion nor dramatic moves, the firm’s recent play in Paris could mark a new phase in BCLP’s post-merger ambitions. Continue reading “‘Our first big move’: Bryan Cave Leighton Paisner gets Paris play over the line”